Cases 111 - 120 of 28,165
Sonos, Inc. v. Linkplay Technology Inc.
as 1:2024cv00131
Counter Defendant:
Sonos, Inc.
Counter Claimant:
Linkplay Technology Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Ninja Transfers, LLC v. DTF, LLC
as 2:2024cv00503
Plaintiff:
Ninja Transfers, LLC
Defendant:
DTF, LLC doing business as NEXTDAYDTF.COM
Cause Of Action: 15 U.S.C. § 1125 Trademark Infringement (Lanham Act)
Chapman Technology Group, Inc. v. RiskOptics, Inc.
as 1:2024cv00394
Plaintiff:
Chapman Technology Group, Inc.
Defendant:
RiskOptics, Inc.
Cause Of Action: 28 U.S.C. § 1331 Fed. Question: Trademark
Bayer HealthCare LLC et al v. Aurobindo Pharma Ltd. et al
as 1:2024cv00399
Plaintiff:
Bayer HealthCare LLC and Meda Pharmaceuticals Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Teva Pharmaceuticals International GmbH et al v. BendaRx USA Corp
as 1:2024cv00395
Plaintiff:
Teva Pharmaceuticals International GmbH, Cephalon, LLC and Eagle Pharmaceuticals Inc.
Defendant:
BendaRx USA Corp
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Azurity Pharmaceuticals, Inc. et al v. Hetero Labs Limited et al
as 1:2024cv00396
Plaintiff:
Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. SANDOZ INC.
as 3:2024cv04327
Plaintiff:
INTRA-CELLULAR THERAPIES, INC.
Defendant:
SANDOZ INC.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. ALKEM LABORATORIES LTD.
as 3:2024cv04312
Plaintiff:
INTRA-CELLULAR THERAPIES, INC.
Defendant:
ALKEM LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. HETERO USA, INC. et al
as 3:2024cv04317
Plaintiff:
INTRA-CELLULAR THERAPIES, INC.
Defendant:
HETERO USA, INC., HETERO LABS LTD. UNIT-V and HETERO LABS LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. MSN LABORATORIES PRIVATE LTD.
as 3:2024cv04325
Plaintiff:
INTRA-CELLULAR THERAPIES, INC.
Defendant:
MSN LABORATORIES PRIVATE LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
